Exchange: PNK Industry: Chemicals
1.06% $0.345
America/New_York / 3 mai 2024 @ 15:58
FUNDAMENTALS | |
---|---|
MarketCap: | 102.10 mill |
EPS: | -0.0200 |
P/E: | -17.25 |
Earnings Date: | May 16, 2024 |
SharesOutstanding: | 295.97 mill |
Avg Daily Volume: | 0.481 mill |
RATING 2024-05-03 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -17.25 | sector: PE -11.58 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -17.25 | industry: PE -7.34 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.322 - 0.368 ( +/- 6.67%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Strommen Jack B. | Buy | 42 857 | Option to Purchase Common Stock |
2024-03-31 | Park Linda | Buy | 53 571 | Option to Purchase Common Stock |
2024-03-31 | Bray Christina Elaine | Buy | 53 571 | Option to Purchase Common Stock |
2024-03-31 | Marshall Dennis E | Buy | 53 571 | Option to Purchase Common Stock |
2024-03-28 | Marshall Dennis E | Buy | 64 176 | Option to Purchase Common Stock |
INSIDER POWER |
---|
94.43 |
Last 99 transactions |
Buy: 9 219 074 | Sell: 356 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.345 (1.06% ) |
Volume | 0.256 mill |
Avg. Vol. | 0.481 mill |
% of Avg. Vol | 53.26 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative and energetic species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and poly-fluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.